Systemic and mucosal pre-administration of recombinant Helicobacter pylori neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice

FEMS Microbiology Letters

Volumn 364, Issue 2, 2017, Pages

  Zhou, Shuai ^a,b   Huang, Yanmei ^a   Liang, Bingshao ^a   Dong, Hui ^a   Yao, Shuwen ^a   Chen, Yinshuang ^a   Xie, Yongqiang ^a   Long, Yan ^a   Gong, Sitang ^a   Zhou, Zhenwen ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG WOMEN AND CHILDREN HOSPITAL   (China)

Author keywords

Allergic asthma; Cytokines; Helicobacter pylori; Inflammation; Neutrophil activating protein

Indexed keywords

ANTIALLERGIC AGENT; BACTERIAL PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN; RECOMBINANT HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOLOGIC FACTOR; NEUTROPHIL-ACTIVATING PROTEIN A, HELICOBACTER PYLORI;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOACCUMULATION; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ADMINISTRATION; DRUG MECHANISM; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; LETTER; MOUSE; MUCOSAL DRUG ADMINISTRATION; NONHUMAN; OPEN READING FRAME; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REGULATORY T LYMPHOCYTE; SYSTEMIC DRUG ADMINISTRATION; TIME SERIES ANALYSIS; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHEMISTRY; CHILD; CYTOLOGY; HUMAN; HYPERSENSITIVITY; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG; MALE; PATHOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BACTERIAL PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAPERITONEAL; LEUKOCYTE COUNT; LUNG; MALE; MICE, INBRED BALB C; OVALBUMIN; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 85014326380     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fnw288     Document Type: Letter

References (35)

1. Akdis CA, Blesken T, Akdis M et al. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
2. Amedei A, Cappon A, Codolo G et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006;116:1092-101.
3. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006;7:956-60.
4. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008;57:561-67.
5. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553-60.
6. Codolo G, Mazzi P, Amedei A et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol 2008;10: 2355-63.
7. D'Elios MM, Codolo G, Amedei A et al. Helicobacter pylori, asthma and allergy. FEMS Immunol Med Mic 2009;56:1-8.
8. D'Elios MM, de Bernard M. To treat or not to treat Helicobacter pylori to benefit asthma patients. Expert Rev Respir Med 2010;4:147-50.
9. D'Elios MM, Manghetti M, De Carli M et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-7.
10. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 2009;136:247-56.
11. Del Prete G, Chiumiento L, Amedei A et al. Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein. J Allergy Clin Immunol 2008;122:908-13.
12. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med 1996;183:1-5.
13. Eder W, EgeMJ, vonMutius E. The asthma epidemic. N Engl J Med 2006;355:2226-35.
14. Finkelman FD, Hogan SP, Khurana Hershey GK et al. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010;184:1663-74.
15. Fu HW. Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications. World J Gastroenterol 2014; 20:5294-301.
16. Freytag LC, Clements JD. Mucosal adjuvants. Vaccine 2005;23:1804-13.
17. Grant RA, Filman DJ, Finkel SE et al. The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat Struct Biol 1998;5:294-303.
18. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-30.
19. Khamechian T, Movahedian AH, Ebrahimi Eskandari G et al. Evaluation of the correlation between childhood asthma and Helicobacter pylori in Kashan. Jundishapur J Microbiol 2015;8:e17842.
20. Lampinen M, Carlson M, Hakansson LD et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59:793-805.
21. Liu X, Fu G, Ji ZY et al. A recombinant DNA plasmid encoding the sIL-4R-NAP fusion protein suppress airway inflammation in an OVA-induced mouse model of asthma. Inflammation 2016;39:1434-40.
22. Mabalirajan U, Ahmad T, Rehman R et al. Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation. PLoS One 2013;8:e62916.
23. Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003;5:715-21.
24. Neumeister P, Troppan K, Raderer M. Management of gastric mucosa-associated lymphoid tissue lymphoma. Dig Dis 2015;33:11-8.
25. Sehrawat A, Sinha S, Saxena A. Helicobacter pylori neutrophilactivating protein: a potential Treg modulator suppressing allergic asthma? Front microbial 2015;6:493.
26. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
27. Taye B, Enquselassie F, Tsegaye A et al. Is Helicobacter Pylori infection inversely associated with atopy? A systematic review and meta-analysis. Clin Exp Allergy 2015;45:882-90.
28. Tighe H, Takabayashi K, Schwartz D et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-34.
29. Tonello F, Dundon WG, Satin B et al. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol 1999;34:238-46.
30. Tournoy KG, Kips JC, Schou C et al. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 2000;30:79-85.
31. Usmani OS. Small airways dysfunction in asthma: evaluation and management to improve asthma control. Allergy Asthma Immunol Res 2014;6:376-88.
32. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
33. Yamaoka Y. Helicobacter pylori: Molecular Genetics and Cellular Biology. Wymondham, UK: Caister Academic Press 2008; 261.
34. Zanotti G, Papinutto E, Dundon W et al. Structure of the neutrophil-activating protein from Helicobacter pylori. J Mol Biol 2002;323:125-30.
35. Zhou ZW, Gong S, LiXMet al. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. J Med Microbiol 2015;64:104-10.